Sabra Health Care REIT, Inc.
NASDAQ:SBRA
18.22 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 655.846 | 624.811 | 569.545 | 598.569 | 661.736 | 623.409 | 405.647 | 260.526 | 238.864 | 183.518 | 134.78 | 103.17 | 84.225 | 8.8 |
| Cost of Revenue
| 378.332 | 162.613 | 141.201 | 131.553 | 108.472 | 49.546 | 17.86 | 5.703 | 2.576 | 3.914 | 0 | 0 | 0 | 0 |
| Gross Profit
| 277.514 | 462.198 | 428.344 | 467.016 | 553.264 | 573.863 | 387.787 | 254.823 | 236.288 | 179.604 | 134.78 | 103.17 | 84.225 | 8.8 |
| Gross Profit Ratio
| 0.423 | 0.74 | 0.752 | 0.78 | 0.836 | 0.921 | 0.956 | 0.978 | 0.989 | 0.979 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 47.472 | 39.574 | 34.669 | 32.755 | 30.462 | 36.458 | 32.401 | 19.918 | 23.865 | 29.339 | 16.423 | 16.104 | 14.473 | 1.6 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 47.472 | 39.574 | 34.669 | 32.755 | 30.462 | 36.458 | 32.401 | 19.918 | 23.865 | 29.339 | 16.423 | 16.104 | 14.473 | 1.6 |
| Other Expenses
| -42.446 | 187.923 | 182.926 | 178.592 | 182.787 | 4.48 | 3.17 | 10.677 | 2.26 | 1.56 | -0.8 | 2.196 | 26.591 | 6.9 |
| Operating Expenses
| 42.446 | 227.497 | 217.595 | 211.347 | 213.249 | 266.912 | 163.396 | 93.933 | 99.786 | 72.671 | 49.704 | 46.367 | 41.064 | 8.5 |
| Operating Income
| 235.068 | 135.572 | 19.041 | 241.224 | 335.313 | 306.951 | 224.391 | 160.89 | 136.502 | 110.847 | 85.076 | 56.803 | 43.161 | 0.2 |
| Operating Income Ratio
| 0.358 | 0.217 | 0.033 | 0.403 | 0.507 | 0.492 | 0.553 | 0.618 | 0.571 | 0.604 | 0.631 | 0.551 | 0.512 | 0.023 |
| Total Other Income Expenses Net
| -227.227 | -211.935 | -130.452 | -102.097 | -262.893 | 122.281 | 23.065 | -25.812 | 2.099 | -16.98 | -10.901 | -0.285 | -30.319 | 0 |
| Income Before Tax
| 7.841 | -76.363 | -111.411 | 139.127 | 72.42 | 282.126 | 159.016 | 70.205 | 79.383 | 46.909 | 33.715 | 19.513 | 12.842 | 0.2 |
| Income Before Tax Ratio
| 0.012 | -0.122 | -0.196 | 0.232 | 0.109 | 0.453 | 0.392 | 0.269 | 0.332 | 0.256 | 0.25 | 0.189 | 0.152 | 0.023 |
| Income Tax Expense
| 2.002 | 1.242 | 1.845 | 0.71 | 3.402 | 3.011 | 0.651 | 75.479 | 61.448 | 48.475 | 39.66 | 39.201 | 0 | 0.242 |
| Net Income
| 13.756 | -77.605 | -113.256 | 138.417 | 68.996 | 279.082 | 158.383 | 70.276 | 79.413 | 46.952 | 33.715 | 19.513 | 12.842 | 7.378 |
| Net Income Ratio
| 0.021 | -0.124 | -0.199 | 0.231 | 0.104 | 0.448 | 0.39 | 0.27 | 0.332 | 0.256 | 0.25 | 0.189 | 0.152 | 0.838 |
| EPS
| 0.06 | -0.34 | -0.52 | 0.67 | 0.37 | 1.57 | 1.4 | 0.92 | 1.11 | 0.79 | 0.69 | 0.53 | 0.43 | 0.29 |
| EPS Diluted
| 0.059 | -0.34 | -0.52 | 0.67 | 0.37 | 1.56 | 1.4 | 0.92 | 1.11 | 0.78 | 0.68 | 0.52 | 0.43 | 0.29 |
| EBITDA
| 418.155 | 323.354 | 198.032 | 417.961 | 516.862 | 505.08 | 341.443 | 240.039 | 201.841 | 155.739 | 117.557 | 89.262 | 69.752 | 3.3 |
| EBITDA Ratio
| 0.638 | 0.518 | 0.348 | 0.698 | 0.781 | 0.81 | 0.842 | 0.921 | 0.845 | 0.849 | 0.872 | 0.865 | 0.828 | 0.375 |